Valuation Guardant Health, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-06 pm EST			5-day change	1st Jan Change
91.20 ^USD	-1.49%		-2.88%	-10.71%

Mar. 05	Guardant Health Insider Sold Shares Worth $3,812,661, According to a Recent SEC Filing	MT
Mar. 04	Guardant Health Launches Coast-To-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to over 100 Communities Across America	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	10,168	2,786	3,283	3,775	13,160	11,963	-	-
Change	-	-72.6%	17.84%	14.96%	248.64%	-9.1%	-	-
Enterprise Value (EV) ¹	10,370	2,912	3,255	4,077	13,462	12,374	12,472	12,294
Change	-	-71.91%	11.75%	25.27%	230.18%	-8.08%	0.79%	-1.43%
P/E ratio	-25x	-4.24x	-6.32x	-8.58x	-30.8x	-31x	-43.1x	-190x
PBR	15.8x	46.4x	20.7x	-27.1x	-134x	-35x	-77.7x	92.1x
PEG	-	-0.1x	0.2x	0.5x	4.57x	2.8x	1.5x	2.5x
Capitalization / Revenue	27.2x	6.2x	5.82x	5.11x	13.4x	9.4x	7.31x	5.74x
EV / Revenue	27.8x	6.48x	5.77x	5.52x	13.7x	9.73x	7.62x	5.9x
EV / EBITDA	-26.7x	-5.84x	-7.46x	-10.2x	-61x	-73.5x	-879x	62.3x
EV / EBIT	-25.2x	-5.35x	-5.76x	-9.19x	-30.8x	-32.3x	-46.5x	-293x
EV / FCF	-36.5x	-7.53x	-9.42x	-14.8x	-57.8x	-52.5x	-97.8x	112x
FCF Yield	-2.74%	-13.3%	-10.6%	-6.74%	-1.73%	-1.9%	-1.02%	0.89%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-4	-6.41	-4.28	-3.56	-3.32	-2.947	-2.116	-0.4807
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	373.7	449.5	563.9	739	982	1,272	1,636	2,083
EBITDA ¹	-388.7	-498.9	-436.3	-399.5	-220.8	-168.4	-14.19	197.3
EBIT ¹	-411	-544.4	-564.7	-443.6	-437.2	-383.1	-268.3	-41.98
Net income ¹	-405.7	-654.6	-479.4	-436.4	-416.3	-379.8	-266.1	-51.83
Net Debt ¹	202.1	126.2	-28.67	302.6	302.4	411.1	509.2	330.9
Reference price ²	100.02	27.20	27.05	30.55	102.14	91.20	91.20	91.20
Nbr of stocks (in thousands)	101,656	102,436	121,380	123,555	128,839	131,170	-	-
Announcement Date	2/23/22	2/23/23	2/22/24	2/20/25	2/19/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GUARDANT HEALTH, INC.	-30.95x	9.73x	-73.47x	-.--%	11.96B
BIOMÉRIEUX	24.74x	2.67x	10.73x	0.97%	13.06B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	25.46x	8.85x	20.35x	2.19%	6.21B
CARIS LIFE SCIENCES, INC.	187.55x	4.64x	28.91x	-.--%	5.25B
LANTHEUS HOLDINGS, INC.	20.25x	3.12x	8.9x	-	4.69B
DIASORIN S.P.A.	20.71x	3.54x	10.79x	1.78%	4.31B
AUTOBIO DIAGNOSTICS CO., LTD.	17.33x	-	-	3.37%	2.9B
10X GENOMICS, INC.	-21.47x	3.55x	-23.32x	-.--%	2.66B
Average	30.45x	5.16x	-2.44x	1.19%	6.38B
Weighted average by Cap.	24.95x	5.60x	-9.02x	0.94%